142 related articles for article (PubMed ID: 16709862)
21. Monoclonal antibodies and synthetic peptides define the active site of FcepsilonRI and a potential receptor antagonist.
Rigby LJ; Trist H; Snider J; Hulett MD; Hogarth PM; Rigby LJ; Epa VC
Allergy; 2000 Jul; 55(7):609-19. PubMed ID: 10921459
[TBL] [Abstract][Full Text] [Related]
22. Fc epsilon RI gamma-ITAM is differentially required for mast cell function in vivo.
Sakurai D; Yamasaki S; Arase K; Park SY; Arase H; Konno A; Saito T
J Immunol; 2004 Feb; 172(4):2374-81. PubMed ID: 14764707
[TBL] [Abstract][Full Text] [Related]
23. Participation of the N-terminal region of Cepsilon3 in the binding of human IgE to its high-affinity receptor FcepsilonRI.
Henry AJ; Cook JP; McDonnell JM; Mackay GA; Shi J; Sutton BJ; Gould HJ
Biochemistry; 1997 Dec; 36(50):15568-78. PubMed ID: 9398285
[TBL] [Abstract][Full Text] [Related]
24. Polymorphisms in the Fc epsilon RI beta promoter region affecting transcription activity: a possible promoter-dependent mechanism for association between Fc epsilon RI beta and atopy.
Nishiyama C; Akizawa Y; Nishiyama M; Tokura T; Kawada H; Mitsuishi K; Hasegawa M; Ito T; Nakano N; Okamoto A; Takagi A; Yagita H; Okumura K; Ogawa H
J Immunol; 2004 Nov; 173(10):6458-64. PubMed ID: 15528387
[TBL] [Abstract][Full Text] [Related]
25. The role of the FcepsilonRI beta-chain in allergic diseases.
Kraft S; Rana S; Jouvin MH; Kinet JP
Int Arch Allergy Immunol; 2004 Sep; 135(1):62-72. PubMed ID: 15316148
[TBL] [Abstract][Full Text] [Related]
26. Human mast cell line-1 (HMC-1) cells transfected with FcεRIα are sensitive to IgE/antigen-mediated stimulation demonstrating selectivity towards cytokine production.
Xia YC; Sun S; Kuek LE; Lopata AL; Hulett MD; Mackay GA
Int Immunopharmacol; 2011 Aug; 11(8):1002-11. PubMed ID: 21356342
[TBL] [Abstract][Full Text] [Related]
27. Mutagenesis within human FcepsilonRIalpha differentially affects human and murine IgE binding.
Mackay GA; Hulett MD; Cook JP; Trist HM; Henry AJ; McDonnell JM; Beavil AJ; Beavil RL; Sutton BJ; Hogarth PM; Gould HJ
J Immunol; 2002 Feb; 168(4):1787-95. PubMed ID: 11823511
[TBL] [Abstract][Full Text] [Related]
28. Necessity of the stalk region for immunoglobulin E interaction with CD23.
Chen BH; Ma C; Caven TH; Chan-Li Y; Beavil A; Beavil R; Gould H; Conrad DH
Immunology; 2002 Nov; 107(3):373-81. PubMed ID: 12423314
[TBL] [Abstract][Full Text] [Related]
29. Functional expression of the high affinity receptor for IgE (FcepsilonRI) in human platelets and its' intracellular expression in human megakaryocytes.
Hasegawa S; Pawankar R; Suzuki K; Nakahata T; Furukawa S; Okumura K; Ra C
Blood; 1999 Apr; 93(8):2543-51. PubMed ID: 10194433
[TBL] [Abstract][Full Text] [Related]
30. Report-Model studies of transmembrane interaction of FcεRIα/FcRγ reveal novel strategies to inhibit allergic responses.
Majeed A; Rashid A; Helm B
Pak J Pharm Sci; 2018 Sep; 31(5):1991-1995. PubMed ID: 30150199
[TBL] [Abstract][Full Text] [Related]
31. Allergy-associated FcRbeta is a molecular amplifier of IgE- and IgG-mediated in vivo responses.
Dombrowicz D; Lin S; Flamand V; Brini AT; Koller BH; Kinet JP
Immunity; 1998 Apr; 8(4):517-29. PubMed ID: 9586641
[TBL] [Abstract][Full Text] [Related]
32. p28, a novel IgE receptor-associated protein, is a sensor of receptor occupation by its ligand in mast cells.
Charles N; Monteiro RC; Benhamou M
J Biol Chem; 2004 Mar; 279(13):12312-8. PubMed ID: 14715661
[TBL] [Abstract][Full Text] [Related]
33. IgE-regulated loss, not IgE-regulated synthesis, controls expression of FcepsilonRI in human basophils.
MacGlashan D; Xia HZ; Schwartz LB; Gong J
J Leukoc Biol; 2001 Aug; 70(2):207-18. PubMed ID: 11493612
[TBL] [Abstract][Full Text] [Related]
34. The membrane-proximal part of FcepsilonRIalpha contributes to human IgE and antibody binding--implications for a general structural motif in Fc receptors.
Nechansky A; Aschauer H; Kricek F
FEBS Lett; 1998 Dec; 441(2):225-30. PubMed ID: 9883889
[TBL] [Abstract][Full Text] [Related]
35. Fine structure analysis of interaction of FcepsilonRI with IgE.
Hulett MD; Brinkworth RI; McKenzie IF; Hogarth PM
J Biol Chem; 1999 May; 274(19):13345-52. PubMed ID: 10224096
[TBL] [Abstract][Full Text] [Related]
36. Efficient folding of the FcepsilonRI alpha-chain membrane-proximal domain D2 depends on the presence of the N-terminal domain D1.
Vangelista L; Cesco-Gaspere M; Lamba D; Burrone O
J Mol Biol; 2002 Sep; 322(4):815-25. PubMed ID: 12270716
[TBL] [Abstract][Full Text] [Related]
37. Cotranslational endoplasmic reticulum assembly of FcepsilonRI controls the formation of functional IgE-binding receptors.
Fiebiger E; Tortorella D; Jouvin MH; Kinet JP; Ploegh HL
J Exp Med; 2005 Jan; 201(2):267-77. PubMed ID: 15642744
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of allergen-specific IgE reactivity by a human Ig Fcgamma-Fcepsilon bifunctional fusion protein.
Zhang K; Kepley CL; Terada T; Zhu D; Perez H; Saxon A
J Allergy Clin Immunol; 2004 Aug; 114(2):321-7. PubMed ID: 15316510
[TBL] [Abstract][Full Text] [Related]
39. Identification of contact residues in the IgE binding site of human FcepsilonRIalpha.
Cook JP; Henry AJ; McDonnell JM; Owens RJ; Sutton BJ; Gould HJ
Biochemistry; 1997 Dec; 36(50):15579-88. PubMed ID: 9398286
[TBL] [Abstract][Full Text] [Related]
40. An immunoglobulin E-reactive chimeric human immunoglobulin G1 anti-idiotype inhibits basophil degranulation through cross-linking of FcepsilonRI with FcgammaRIIb.
Wigginton SJ; Furtado PB; Armour KL; Clark MR; Robins A; Emara M; Ghaemmaghami AM; Sewell HF; Shakib F
Clin Exp Allergy; 2008 Feb; 38(2):313-9. PubMed ID: 18070161
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
